TABLE 3

Clinical pharmacokinetic and drug-drug interaction data

Category of Clinical InducerInteracting DrugCmax-tCmax-uAUCVictim DrugObserved 
AUC ChangeReferences
μMμMH ⋅ μM%
Strong, ≥80% decrease in AUCRifampicina153.634Midazolam98Backman et al., 1998; 
Kanebratt and Anderson, 2008
Rifampicina112.734Midazolam95Eap et al., 2004
Rifampicina102.534Midazolam97Fahmi et al., 2012; 
Backman et al., 1996a
Rifampicina6.51.634Midazolam86Adams et al., 2005
Phenytoina297.3468Midazolam94Backman et al., 1996b; 
Kanebratt and Anderson, 2008
Carbamazepinea215.31248Midazolam94Backman et al., 1996b; 
Kanebratt and Anderson, 2008
Carbamazepine256.11248Alprazolam58Furukori et al.,1998
Moderate, 50–80% decrease 
in AUCPhenobarbital56281497Nifedipine61Schellens et al., 1989, 
Kanebratt and Anderson, 2008
Troglitazone3.10.03124Simvastatin38Fahmi et al., 2012; 
Prueksaritanont et al., 2001; 
Kanebratt and Anderson, 2008
Troglitazonea6.30.06350Midazolam67Fahmi et al., 2012
Weak, 
20–50% decrease 
in AUCTerbinafinea2.40.02416Midazolam25Ahonen, et al., 1995
Pleconarila3.00.03042Midazolam35Ma, et al., 2006; 
Fahmi and Ripp, 2010
Pioglitazone4.50.04544Simvastatin−1Prueksaritanont et al., 2001; Fahmi and Ripp, 2010
Pioglitazonea2.80.02844Midazolam26Fahmi et al., 2012
Sulfinpyrazone480.96287R-Warfarin22O'Reilly, 1982; 
Kanebratt and Andersson, 2008
Probenecid244242705Carbamazepine20Kim et al., 2005; Selen et al., 1982
Clinical 
noninducerDexamethasone0.0210.00540.29Triazolam19Fahmi et al., 2012; 
Kanebratt and Andersson, 2008
Nifedipinea0.400.0200.87Midazolam4Fahmi et al., 2012;
Kanebratt and Andersson, 2008
Rosiglitazone1.70.00338.2Nifedipine12Fahmi et al., 2012; 
Harris et al., 1999; 
Fahmi and Ripp, 2010
Rosiglitazone1.40.00288.2Ethinylestradiol−1Inglis A et al., 2001; 
Fahmi and Ripp, 2010
Omeprazole0.740.0371.1Nifedipine−25Soons, et al., 1992; 
Kanebratt and Andersson, 2008
Clotrimazolea0.00740.0001NAMidazolam9.7Shord et al., 2010
Flumazenil0.00100.00050.050Midazolam−2Fahmi et al., 2012
Quinidine3.30.4142NA0Mihaly et al.,1987; 
Leizorovicz et al., 1984
  • NA, clinical induction interaction data not available.

  • a Interacting drugs used for preparation of calibration curves.